Robinson, Prema, et al. “Substance P Neurokinin 1 Receptor Involvement in Breast Cancer Progression Supports Therapeutic Repurposing of the Drug Aprepitant”. International Journal of Translational Science, vol. 2025, no. 2, Feb. 2026, pp. 153–164, doi:10.13052/ijts2246-8765.2025.023.